EDGAR 2.0: an enhanced software platform for comparative gene content analyses

Jochen Blom, Julian Kreis, Sebastian Spänig, +4

Nucleic Acids Research

Enhanced Software PlatformGeneticsGenomicsBioinformatics DatabaseHigh Throughput Sequencing +24

Mutational dynamics between primary and relapse neuroblastomas

Alexander Schramm, Johannes Köster, Yassen Assenov, +30

Nature Genetics

Tumor HeterogeneityMutational DynamicsPathologyNeuroblastsMedicine +2

Gene panel testing of 5589 <i><scp>BRCA</scp>1/2</i>‐negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer

Jan Hauke, Judit Horváth, Eva Groß, +42

Cancer Medicine

Computational Pan-Genomics: Status, Promises and Challenges

Tobias Marschall, Manja Marz, Thomas Abeel, +56

EngineeringGeneticsReference GenomesGenomicsBioinformatics Database +19

BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer

Nana Weber‐Lassalle, Jan Hauke, Juliane Ramser, +34

Breast Cancer Research

Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics

Corinna Ernst, Eric Hahnen, Christoph Engel, +4

BMC Medical Genomics

Association Between Loss-of-Function Mutations Within the <i>FANCM</i> Gene and Early-Onset Familial Breast Cancer

Guido Neidhardt, Jan Hauke, Juliane Ramser, +24

JAMA Oncology

How to make a tumour: cell type specific dissection of <i>Ustilago maydis‐</i> induced tumour development in maize leaves

Alexandra Matei, Corinna Ernst, Markus Günl, +5

New Phytologist

Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer

Nana Weber‐Lassalle, Julika Borde, Konstantin Weber‐Lassalle, +26

Breast Cancer Research

Association of Germline Variant Status With Therapy Response in High-risk Early-Stage Breast Cancer

Esther Pohl‐Rescigno, Jan Hauke, Sibylle Loibl, +22

JAMA Oncology